Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Crizotinib 1.4.3 Alectinib 1.4.4 Ceritinib 1.4.5 Brigatinib 1.4.6 Other 1.5 Market by Application 1.5.1 Global ALK Positive Lung Cancer Treatment Market Share by Application (2019-2025) 1.5.2 Hospital 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 ALK Positive Lung Cancer Treatment Market Size 2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions 2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions (2019-2025) 2.2.2 ALK Positive Lung Cancer Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 ALK Positive Lung Cancer Treatment Market Size by by Players 3.1.1 Global ALK Positive Lung Cancer Treatment Revenue by by Players (2014-2019) 3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by by Players (2014-2019) 3.1.3 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.2 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served 3.3 Key Players ALK Positive Lung Cancer Treatment Product/Solution/Service 3.4 Date of Enter into ALK Positive Lung Cancer Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global ALK Positive Lung Cancer Treatment Market Size by Type (2014-2019) 4.2 Global ALK Positive Lung Cancer Treatment Market Size by Application (2014-2019) 5 North America 5.1 North America ALK Positive Lung Cancer Treatment Market Size (2014-2019) 5.2 ALK Positive Lung Cancer Treatment Key Players in North America 5.3 North America ALK Positive Lung Cancer Treatment Market Size by Type 5.4 North America ALK Positive Lung Cancer Treatment Market Size by Application 6 Europe 6.1 Europe ALK Positive Lung Cancer Treatment Market Size (2014-2019) 6.2 ALK Positive Lung Cancer Treatment Key Players in Europe 6.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type 6.4 Europe ALK Positive Lung Cancer Treatment Market Size by Application 7 China 7.1 China ALK Positive Lung Cancer Treatment Market Size (2014-2019) 7.2 ALK Positive Lung Cancer Treatment Key Players in China 7.3 China ALK Positive Lung Cancer Treatment Market Size by Type 7.4 China ALK Positive Lung Cancer Treatment Market Size by Application 8 Japan 8.1 Japan ALK Positive Lung Cancer Treatment Market Size (2014-2019) 8.2 ALK Positive Lung Cancer Treatment Key Players in Japan 8.3 Japan ALK Positive Lung Cancer Treatment Market Size by Type 8.4 Japan ALK Positive Lung Cancer Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia ALK Positive Lung Cancer Treatment Market Size (2014-2019) 9.2 ALK Positive Lung Cancer Treatment Key Players in Southeast Asia 9.3 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type 9.4 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application 10 India 10.1 India ALK Positive Lung Cancer Treatment Market Size (2014-2019) 10.2 ALK Positive Lung Cancer Treatment Key Players in India 10.3 India ALK Positive Lung Cancer Treatment Market Size by Type 10.4 India ALK Positive Lung Cancer Treatment Market Size by Application 11 Central & South America 11.1 Central & South America ALK Positive Lung Cancer Treatment Market Size (2014-2019) 11.2 ALK Positive Lung Cancer Treatment Key Players in Central & South America 11.3 Central & South America ALK Positive Lung Cancer Treatment Market Size by Type 11.4 Central & South America ALK Positive Lung Cancer Treatment Market Size by Application 12 International Players Profiles 12.1 F. Hoffmann-La Roche 12.1.1 F. Hoffmann-La Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 ALK Positive Lung Cancer Treatment Introduction 12.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019)) 12.1.5 F. Hoffmann-La Roche Recent Development 12.2 Pfizer 12.2.1 Pfizer Company Details 12.2.2 Company Description and Business Overview 12.2.3 ALK Positive Lung Cancer Treatment Introduction 12.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.2.5 Pfizer Recent Development 12.3 Novartis 12.3.1 Novartis Company Details 12.3.2 Company Description and Business Overview 12.3.3 ALK Positive Lung Cancer Treatment Introduction 12.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.3.5 Novartis Recent Development 12.4 TP Therapeutics 12.4.1 TP Therapeutics Company Details 12.4.2 Company Description and Business Overview 12.4.3 ALK Positive Lung Cancer Treatment Introduction 12.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.4.5 TP Therapeutics Recent Development 12.5 Bristol-Myers Squibb 12.5.1 Bristol-Myers Squibb Company Details 12.5.2 Company Description and Business Overview 12.5.3 ALK Positive Lung Cancer Treatment Introduction 12.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.5.5 Bristol-Myers Squibb Recent Development 12.6 Eli Lilly and Company 12.6.1 Eli Lilly and Company Company Details 12.6.2 Company Description and Business Overview 12.6.3 ALK Positive Lung Cancer Treatment Introduction 12.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.6.5 Eli Lilly and Company Recent Development 12.7 Takeda 12.7.1 Takeda Company Details 12.7.2 Company Description and Business Overview 12.7.3 ALK Positive Lung Cancer Treatment Introduction 12.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.7.5 Takeda Recent Development 12.8 Beacon Pharma 12.8.1 Beacon Pharma Company Details 12.8.2 Company Description and Business Overview 12.8.3 ALK Positive Lung Cancer Treatment Introduction 12.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2014-2019) 12.8.5 Beacon Pharma Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table ALK Positive Lung Cancer Treatment Key Market Segments Table Key Players ALK Positive Lung Cancer Treatment Covered Table Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Crizotinib Figures Table Key Players of Crizotinib Figuer Alectinib Figures Table Key Players of Alectinib Figuer Ceritinib Figures Table Key Players of Ceritinib Figuer Brigatinib Figures Table Key Players of Brigatinib Figuer Other Figures Table Key Players of Other Table Global ALK Positive Lung Cancer Treatment Market Size Growth by Application 2019-2025 (Million US$) Figure Global ALK Positive Lung Cancer Treatment Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinics Case Studies Figure Other Case Studies Figure ALK Positive Lung Cancer Treatment Report Years Considered Figure Global ALK Positive Lung Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Size by Regions 2019-2025 (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Size by Regions 2019-2025 (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Share by Regions 2014-2019 Figure Global ALK Positive Lung Cancer Treatment Market Share by Regions 2014-2019 Figure Global ALK Positive Lung Cancer Treatment Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global ALK Positive Lung Cancer Treatment Revenue by by Players (2014-2019) (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Share by by Players (2014-2019) Figure Global ALK Positive Lung Cancer Treatment Market Share by by Players in 2018 Table Global ALK Positive Lung Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players ALK Positive Lung Cancer Treatment Product/Solution/Service Table Date of Enter into ALK Positive Lung Cancer Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global ALK Positive Lung Cancer Treatment Market Size by Type (2014-2019) (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Size Share by Type (2014-2019) Figure Global ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2014-2019) Table Global ALK Positive Lung Cancer Treatment Market Size by Application (2014-2019) (Million US$) Table Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2014-2019) Figure Global ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2014-2019) Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application in 2018 Figure North America ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table North America Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table North America Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table North America ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table North America ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table North America ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table North America ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure Europe ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table Europe ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table Europe ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table Europe ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table Europe ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure China ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table China Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table China Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table China ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table China ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table China ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table China ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure Japan ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table Japan ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table Japan ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table Japan ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table Japan ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure Southeast Asia ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure India ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table India Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table India Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table India ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table India ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table India ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table India ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Figure Central & South America ALK Positive Lung Cancer Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players ALK Positive Lung Cancer Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players ALK Positive Lung Cancer Treatment Market Share (2018-2019) Table Central & South America ALK Positive Lung Cancer Treatment Market Size by Type 2014-2019 (Million US$) Table Central & South America ALK Positive Lung Cancer Treatment Market Share by Type 2014-2019 Table Central & South America ALK Positive Lung Cancer Treatment Market Size by Application 2014-2019 (Million US$) Table Central & South America ALK Positive Lung Cancer Treatment Market Share by Application 2014-2019 Table F. Hoffmann-La Roche Company Details Table F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table F. Hoffmann-La Roche Recent Development Table Pfizer Company Details Table Pfizer Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Pfizer Recent Development Table Novartis Company Details Table Novartis Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Novartis Recent Development Table TP Therapeutics Company Details Table TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table TP Therapeutics Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Eli Lilly and Company Company Details Table Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Eli Lilly and Company Recent Development Table Takeda Company Details Table Takeda Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Takeda Recent Development Table Beacon Pharma Company Details Table Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business 2014-2019 (Million US$) Figure Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2014-2019) Table Beacon Pharma Recent Development Table Global ALK Positive Lung Cancer Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global ALK Positive Lung Cancer Treatment Market Size Share by Regions (2019-2025) Figure Global ALK Positive Lung Cancer Treatment Market Size Share by Regions in 2025 Figure North America ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure China ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure India ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America ALK Positive Lung Cancer Treatment Market Size Forecast (2019-2025)(Million USD) Table Global ALK Positive Lung Cancer Treatment Market Size by Product (2019-2025) (Million US$) Figure Global ALK Positive Lung Cancer Treatment Market Size by Product (2019-2025) Figure Global ALK Positive Lung Cancer Treatment Market Size by Product in 2025 Table Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2025) (Million US$) Figure Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2025) Figure Global ALK Positive Lung Cancer Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

F. Hoffmann-La Roche Pfizer Novartis TP Therapeutics Bristol-Myers Squibb Eli Lilly and Company Takeda Beacon Pharma